Indaptus Therapeutics, Inc. (INDP)

NASDAQ

$2.82

$+0.13

(+4.58%)

Regular Market

Indaptus Therapeutics, Inc. (INDP) Live Price Chart

Last updated: ⁦2026-10-20 18:33:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Indaptus Therapeutics, Inc. (INDP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.82, with a market capitalization of $350.43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.92 to $5.96. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$350.43M
Open	$2.75
Day's High	$807.24
Day's Low	$0.92
Previous Close	$2.73
Volume	114.34K
Average Volume	899.30K
P/E Ratio	--
52-Week High	$5.96
52-Week Low	$0.92
Dividend Yield	--
Earnings Date	--

Indaptus Therapeutics, Inc. (INDP) Stock Price Today

Indaptus Therapeutics, Inc. (INDP) is currently trading at $2.82 as of 2026-10-20 18:28:00, up 3.30% ($0.09) from the previous close of $2.73

During today's regular trading session, INDP has traded between $0.92 and $807.24, with a trading volume of 114.34K shares. The current price is near the lower end of today's range.

Indaptus Therapeutics, Inc. (INDP) 7-Day Stock Price Change

Over the past seven days, Indaptus Therapeutics, Inc. (INDP) moved from $2.51 to $2.82, representing a gain of 12.35% ($0.31).

The stock traded between $2.03 and $2.92 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 487.22 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

INDP 52-Week Price Position

Position in Range: 37.7%

52W Low$0.92

52W High$5.96

INDP is currently trading at $2.82, placing it 37.7% of the way from its 52-week low of $0.92 to its 52-week high of $5.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Indaptus Therapeutics, Inc. (INDP)?

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Indaptus Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.indaptusrx.com

How to Buy Indaptus Therapeutics, Inc. (INDP) Stock on MEXC

Eligible investors can buy real shares of Indaptus Therapeutics, Inc. (INDP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INDP and Place Your Order

Open the RealStocks trading page and search for INDP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Indaptus Therapeutics, Inc. (INDP) stock price today?

Indaptus Therapeutics, Inc. (INDP) is currently trading at $ 2.82, up 3.30% ($0.09) from the previous close of $ 2.73. Intraday prices update in real time during regular trading hours.

2.Is INDP stock going up or down today?

As of 2026-10-20 18:28:00, INDP is trading at $ 2.82, up 3.30% ($0.09) from its previous close of $ 2.73. The stock has traded between $ 0.92 and $ 807.24 during today’s regular session. Past price movements do not guarantee future results.

3.What is INDP pre-market price?

As of 2026-10-20 18:28:00, INDP is trading at $ 2.73 in pre-market trading, down 0.18% ($0.00) from the previous close of $ 2.73. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INDP after-hours price?

As of 2026-10-20 18:28:00, INDP is trading at $ 2.66 in after-hours trading, down 2.56% ($0.07) from the regular-session close of $ 2.73. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INDP stock trading now?

INDP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INDP sit relative to its 52-week high and low?

Over the past 52 weeks, INDP has traded between a low of $ 0.92 and a high of $ 5.96. At $ 2.82, the stock is positioned 37.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Indaptus Therapeutics, Inc. in?

Indaptus Therapeutics, Inc. (INDP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Indaptus Therapeutics, Inc.'s market capitalization and where is it listed?

Indaptus Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 350.43M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INDP valued in terms of P/E ratio and EPS?

INDP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.12. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Indaptus Therapeutics, Inc. pay a dividend?

Indaptus Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.